Romero-Zerbo, S. Y., García-Fernández, M., Espinosa-Jiménez, V., Pozo-Morales, M., Escamilla-Sánchez, A., Sánchez-Salido, L., . . . Bermúdez-Silva, F. J. (2020). The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne).
Citação norma ChicagoRomero-Zerbo, Silvana Y., et al. "The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease." Front Endocrinol (Lausanne) 2020.
Citação norma MLARomero-Zerbo, Silvana Y., et al. "The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease." Front Endocrinol (Lausanne) 2020.